Valeant Pharmaceuticals (VRX) Announces $1.5B Securites Repurchase Program
Tweet Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced an $1.5 billion securities repurchase program.
Under ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Under ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
